MyAverix Finance
SA · Healthcare
Galapagos NV (G1LP34)
Biotechnology
Galapagos NV (G1LP34) is listed on SA in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for G1LP34
Galapagos NV (G1LP34) — FAQ
What is G1LP34's P/E ratio?
The price-to-earnings (P/E) ratio for Galapagos NV (G1LP34) is 25.00 (data as of 2026-05-23).
Does Galapagos NV pay a dividend?
Dividend yield is not available in the current snapshot for Galapagos NV (G1LP34). Check the MyAverix Finance app for the latest dividend data.
What sector is Galapagos NV in?
Galapagos NV (G1LP34) is classified in the Healthcare sector (Biotechnology industry).
What exchange is G1LP34 listed on?
G1LP34 is listed on SA.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.